ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
eric341
|
3.0K |
1.1M |
1 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
3.0K
|
1.1M
|
1
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
eric341
|
3.0K |
1.1M |
0 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
3.0K
|
1.1M
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
eric341
|
84K |
50M |
4 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
84K
|
50M
|
4
|
|
ASX - By Stock
|
LSF |
Re:
$3.00 NTA
|
|
eric341
|
39 |
9.8K |
3 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
39
|
9.8K
|
3
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
eric341
|
25K |
13M |
0 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
25K
|
13M
|
0
|
|
ASX - By Stock
|
DLI |
Re:
Ann: Exceptional Maiden Diamond Assays, 34.17m @ 1.32% Li2O
|
|
eric341
|
65 |
24K |
1 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
65
|
24K
|
1
|
|
ASX - By Stock
|
TER |
Re:
Ann: Quarterly Report - January to March 2022
|
|
eric341
|
157 |
66K |
1 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
157
|
66K
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
eric341
|
25K |
13M |
3 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
25K
|
13M
|
3
|
|
ASX - By Stock
|
DLI |
Re:
Ann: Exceptional Maiden Diamond Assays, 34.17m @ 1.32% Li2O
|
|
eric341
|
65 |
24K |
7 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
65
|
24K
|
7
|
|
ASX - By Stock
|
LSF |
Re:
Ann: Net Tangible Asset Backing
|
|
eric341
|
12 |
2.6K |
2 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
12
|
2.6K
|
2
|
|
ASX - By Stock
|
LSF |
Re:
Ann: Net Tangible Asset Backing
|
|
eric341
|
12 |
2.6K |
0 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
12
|
2.6K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Suspension from Official Quotation
|
|
eric341
|
422 |
268K |
9 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
422
|
268K
|
9
|
|
ASX - By Stock
|
NST |
Re:
Best looking weekly chart
|
|
eric341
|
2.3K |
1.0M |
11 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
2.3K
|
1.0M
|
11
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Suspension from Official Quotation
|
|
eric341
|
422 |
268K |
8 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
422
|
268K
|
8
|
|
ASX - By Stock
|
AIS |
Re:
Ann: RETAIL OFFER DOCUMENT
|
|
eric341
|
120 |
45K |
2 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
120
|
45K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
eric341
|
23K |
8.1M |
1 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
23K
|
8.1M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMU RECEIVES ETHICS APPROVAL TO START HER-VAXX NextHERIZON
|
|
eric341
|
81 |
47K |
1 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
81
|
47K
|
1
|
|
ASX - By Stock
|
QFE |
Re:
QFE - Chart
|
|
eric341
|
851 |
441K |
0 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
851
|
441K
|
0
|
|
ASX - By Stock
|
LKE |
Re:
LKE towards TOP-5
|
|
eric341
|
24K |
6.7M |
4 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
24K
|
6.7M
|
4
|
|
ASX - By Stock
|
ATG |
Re:
Rbl charts
|
|
eric341
|
271 |
121K |
0 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
271
|
121K
|
0
|
|
ASX - By Stock
|
QFE |
Re:
QFE - Chart
|
|
eric341
|
851 |
441K |
0 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
851
|
441K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
eric341
|
1.5K |
517K |
2 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
1.5K
|
517K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: EMVision Secures Strategic Agreement With Keysight
|
|
eric341
|
41 |
12K |
0 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
41
|
12K
|
0
|
|
ASX - General
|
|
Re:
Shorting the ASX
|
|
eric341
|
5 |
1.6K |
0 |
10/05/22 |
10/05/22 |
ASX - General
|
5
|
1.6K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
eric341
|
1.5K |
517K |
2 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
1.5K
|
517K
|
2
|
|
ASX - By Stock
|
QFE |
Re:
QFE - Chart
|
|
eric341
|
851 |
441K |
1 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
851
|
441K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
eric341
|
1.5K |
517K |
1 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
1.5K
|
517K
|
1
|
|
ASX - By Stock
|
MLS |
Re:
Ann: Spectacular Zinc Intersection & Sulphide Discovery - Manindi
|
|
eric341
|
189 |
56K |
4 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
189
|
56K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: EMVision Secures Strategic Agreement With Keysight
|
|
eric341
|
41 |
12K |
1 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
41
|
12K
|
1
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Stunning Drill Results 68m @ 2.4% Copper at Greater Duchess
|
|
eric341
|
209 |
104K |
2 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
209
|
104K
|
2
|
|
ASX - General
|
|
Shorting the ASX
|
|
eric341
|
5 |
1.6K |
0 |
10/05/22 |
10/05/22 |
ASX - General
|
5
|
1.6K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Trading Halt
|
|
eric341
|
172 |
129K |
3 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
172
|
129K
|
3
|
|
ASX - By Stock
|
AMS |
Re:
Ann: Trading Update
|
|
eric341
|
194 |
83K |
1 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
194
|
83K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
eric341
|
1.5K |
517K |
1 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
1.5K
|
517K
|
1
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
eric341
|
2.1K |
653K |
2 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
2.1K
|
653K
|
2
|
|
Charts
|
EOS |
Re:
EOS Charts
|
|
eric341
|
2.6K |
1.7M |
2 |
10/05/22 |
10/05/22 |
Charts
|
2.6K
|
1.7M
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
eric341
|
23K |
8.1M |
5 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
23K
|
8.1M
|
5
|
|
ASX - By Stock
|
QFE |
Re:
QFE - Chart
|
|
eric341
|
851 |
441K |
1 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
851
|
441K
|
1
|
|
ASX - By Stock
|
AMS |
Re:
Ann: Trading Update
|
|
eric341
|
194 |
83K |
1 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
194
|
83K
|
1
|
|
ASX - By Stock
|
RZI |
Re:
Ann: April 2022 - Key Metrics
|
|
eric341
|
15 |
8.3K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
15
|
8.3K
|
0
|
|
ASX - By Stock
|
AMS |
Re:
Ann: Trading Update
|
|
eric341
|
194 |
83K |
1 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
194
|
83K
|
1
|
|
ASX - By Stock
|
TER |
Re:
Ann: Quarterly Report - January to March 2022
|
|
eric341
|
157 |
66K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
157
|
66K
|
0
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
eric341
|
2.1K |
653K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
2.1K
|
653K
|
0
|
|
ASX - By Stock
|
BET |
Re:
Bet your longs
|
|
eric341
|
345 |
149K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
345
|
149K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
eric341
|
84K |
50M |
7 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
84K
|
50M
|
7
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Ryberg 2021 Drilling and Geophysical Results
|
|
eric341
|
184 |
47K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
184
|
47K
|
0
|
|
ASX - By Stock
|
BET |
Re:
Bet your longs
|
|
eric341
|
345 |
149K |
2 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
345
|
149K
|
2
|
|
ASX - By Stock
|
BET |
Re:
Bet your longs
|
|
eric341
|
345 |
149K |
2 |
07/05/22 |
07/05/22 |
ASX - By Stock
|
345
|
149K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
eric341
|
23K |
8.1M |
1 |
07/05/22 |
07/05/22 |
ASX - By Stock
|
23K
|
8.1M
|
1
|
|
ASX - By Stock
|
EL8 |
Re:
Ann: Investor Webinar
|
|
eric341
|
12 |
6.3K |
1 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
12
|
6.3K
|
1
|
|